Warning letter
Med-Pharmex, Inc.: warning letter of May 17, 2017
FDA warning letter 522676 · Los Angeles District Office
Key facts
| Reference number | 522676 |
|---|---|
| Company | Med-Pharmex, Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | May 17, 2017 |
| Posted date | May 30, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Veterinary |
| CFR sections cited | 211, 211.42(c)(10)(iii), 211.42(c)(10)(iv), 211.42(c)(10)(v), 211.68(b), 211.113(b), 211.194(a) |
| Inspection city | Pomona |
| Inspection ZIP | 91767 |
| Inspection start date | Jan 17, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: